These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21158721)

  • 1. Molecular targeting of liposomal nano-particles to lymphatic system.
    Cuong NV; Hsieh MF
    Curr Cancer Drug Targets; 2011 Feb; 11(2):147-55. PubMed ID: 21158721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.
    Cai S; Yang Q; Bagby TR; Forrest ML
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):901-8. PubMed ID: 21712055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.
    Xie Y; Bagby TR; Cohen MS; Forrest ML
    Expert Opin Drug Deliv; 2009 Aug; 6(8):785-92. PubMed ID: 19563270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.
    Ryan GM; Kaminskas LM; Porter CJ
    J Control Release; 2014 Nov; 193():241-56. PubMed ID: 24801249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
    Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
    Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
    Parker RJ; Hartman KD; Sieber SM
    Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
    Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
    J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin.
    Ryan GM; Kaminskas LM; Bulitta JB; McIntosh MP; Owen DJ; Porter CJH
    J Control Release; 2013 Nov; 172(1):128-136. PubMed ID: 23954628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
    Oussoren C; Zuidema J; Crommelin DJ; Storm G
    Biochim Biophys Acta; 1997 Sep; 1328(2):261-72. PubMed ID: 9315622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in lymphatic imaging and drug delivery.
    Nune SK; Gunda P; Majeti BK; Thallapally PK; Forrest ML
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):876-85. PubMed ID: 21718728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal systems for tumor targeting.
    Storm G; Crommelin DJ
    Hybridoma; 1997 Feb; 16(1):119-25. PubMed ID: 9085138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes to target the lymphatics by subcutaneous administration.
    Oussoren C; Storm G
    Adv Drug Deliv Rev; 2001 Aug; 50(1-2):143-56. PubMed ID: 11489337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Self-Assembly Nanocrystal as Lymph Node-Targeting Delivery System: Higher Activity of Lymph Node Targeting and Longer Efficacy Against Lymphatic Metastasis.
    Mao Y; Liu J; Shi T; Chen G; Wang S
    AAPS PharmSciTech; 2019 Aug; 20(7):292. PubMed ID: 31428888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Targeted-liposome Delivery System of Antitumor Drugs.
    Wu WD; Yi XL; Jiang LX; Li YZ; Gao J; Zeng Y; Yi RD; Dai LP; Li W; Ci XY; Si DY; Liu CX
    Curr Drug Metab; 2015; 16(10):894-910. PubMed ID: 26652257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.